Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Celgene's thalidomide approvable for ENL

Sep. 23, 1997

Tacrolimus ointment effective in animal model of contact dermatitis

Sep. 19, 1997

Clinical update on Dermagraft

Sep. 19, 1997

Retinoid-like compounds from Allergan

Sep. 18, 1997

Gliatech cleared to begin U.S. clinical trials of third ADCON product

Sep. 12, 1997

Expanded uses of LifeCell's AlloDerm discussed at recent meeting

Sep. 11, 1997

Ortec's CCS advances in clinical development

Sep. 10, 1997

Genzyme Transgenics, Bristol-Myers Squibb to codevelop second recombinant transgenic drug

Sep. 10, 1997

FDA advisory committee recommends thalidomide for approval

Sep. 8, 1997

New antiandrogenic compounds prepared at Roussel Uclaf

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.